2016 U.S. Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

Publisher Name :
Date: 12-Nov-2015
No. of pages: 460

VPGMarketResearch.com's new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

Rationale

During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations


  • New product development opportunities with significant market appeal.

  • Alternative market penetration strategies.

  • Potential market entry barriers and risks.


The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis


  • Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product.


Competitive Assessments


  • Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.


Market Segmentation Analysis


  • Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.

  • Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:

  • Blood Centers

  • Plasma Fractionation Facilities

  • Hospitals

  • Commercial/Private Laboratories

  • Military Blood Banks


Current and Emerging Products


  • Analysis of current and emerging blood banking tests.

  • Review of automated and semi-automated analyzers, including their operating characteristics, features, and selling prices.


Technology Review


  • Assessment of current and emerging technologies, and their potential applications for the blood banking market.

  • Comprehensive lists of companies developing or marketing new technologies and products by test.

2016 U.S. Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies

Table of Contents

I. Introduction

II. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Blood Group Genotyping
a. PCR
b. PCR-RFLP
c. AS-PCR or PCR-SSP
d. Multiplex PCR
e. Real Time PCR
f. Sanger DNA Sequencing
g. Pyrosequencing
b. Microarrays
- BeadChip Array
- BloodChip
- Genome Lab SNP Stream
- Fluidic Microarray Systems
- TaqMan OpenArray
- MALDI-TOF-MS
- Mini-Sequencing
3. Infectious Disease Screening Tests
a. AIDS
- Structure and Composition
- Classification
- Origin of AIDS
- Animal Lentivirus Systems
- Virus Receptors
- HIV Infections in Humans
-Pathogenesis & Pathology
-Overview of Course of HIV Infection
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
-Clinical Findings
- Plasma Viral Load
- Pediactric AIDS
-Neurologic Disease
-Opportunistic Infections
-Protozoa
-Fungi
-Bacteria
- Viruses
- Cancer
- Immunity
- Laboratory Diagnosis
-Virus Isolation
-Serology
-Detection of Viral Nucleic Acid or Antigens
- Epidemiology
-Worldwide Spread of AIDS
-United States
-Routes of Transmission
- Prevention, Treatment, And Control
-Antiviral Drugs
-Vaccines Against HIV
- Transmission of HIV in Blood Products
- HIV Transmission in Transplant and Artificial Insemination Recipients
- Diagnostic Tests
- Enzyme Immunoassay Interpretation
- Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
- Competition Assays
- Western Blot Technique
- Immuno-Fluorescence Assay (IFA)
- Radioimmunoprecipitation
- HIV-1/HIV-2 Combination Testing
- Methods of HIV-Antigen Detection
- Antigen Assays and Blood Screening
- Urine Tests
- DNA Probes
- Overview
- Quantitative Polymerase Chain Reaction
- In Situ PCR
- Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis
- Hepatitis A
- Hepatitis B
-Structure and Composition
-Replication of Hepatitis B Virus
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Hepatitis Virus Infections In Humans
-Pathology
- Clinical Findings
- Laboratory Features
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D
-Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D (Delta Agent)
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
-Erythema Infectiosum Slapped (cheek)
-Adult Polyarthropathy
-Transient Aplastic Crisis
-Transient Pancytopenia
-Red Cell Aplasia in the Immunocompromised
-Perinatal Infections
- Diagnosis
- Treatment
g. Creutzfeldt-Jakob's Disease
- Background
- Transmission
- Diagnostic Tests
- Major Commercial and Academic Players
-Bayer
-Disease Sciences/BioTec Global
-Imperial College School of Medicine
-Ortho-Clinical Diagnostics
-Pall
-ProMetic Life Sciences
-Proteome Sciences/Idexx
-Q-One Biotech
-Serono
-U.S. Agricultural Research Service
- Drugs
- Vaccines
h. Malaria
i. Chagas Disease
j. Babesiosis
4. Pathogen Reduction
5. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- BioMerieux
- Cepheid
- Curtis Unyvero
- Gen-Probe/Hologic
- GenMark
- Grifols
- HTG
- Immucor
- Life Technologies
- Nanosphere
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Sarstedt
- Siemens
- Tecan
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Molecular Diagnostics
a. Overview
b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing

III. U.S.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

IV. Major Product Development Opportunities
A. Molecular Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts

VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

VII. Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- CellMark Forensics/LabCorp
- Diagast
- DiaSorin
- Fujirebio
- Hologic/Gen-Probe
- Grifols
- Immucor
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens
- Tecan
- Thermo Fisher

List of Tables

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers

Executive Summary Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
U.S.A., Estimated Number of Inpatient and Ambulatory Surgeries
U.S.A., Facilities Performing Blood Bank Tests by Market Segment
U.S.A., Hospital Laboratories Performing Blood Bank Tests by Bed Size
U.S.A., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood and Plasma by Market Forecast Segment
U.S.A., Whole Blood and Plasma Collections by Market Forecast Segment
U.S.A., All Market Segments Blood Typing and Grouping Test Volume by Market Forecast Segment
U.S.A., All Market Segments Blood Typing and Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume Forecast
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast
U.S.A., Community and Regional Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume Forecast
U.S.A., Military Blood Banks Infectious Disease Screening Test Volume Forecast
U.S.A., All Market Segments Blood Typing and Grouping Reagent Market Forecast by Market Segment
U.S.A., All Market Segments Blood Typing and Grouping Reagent Market Forecast by Market Segment
U.S.A., Hospital Blood Banks Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Military Blood Banks Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Major Suppliers of Blood Typing and Grouping Reagents Estimated Sales and Market Shares
U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier
U.S.A., Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major Supplier
U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier
U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier

  • Global Cellular Health Screening/Health Testing Market Research Report 2017-2022 by Players, Regions, Product Types & Applications
    Published: 17-Oct-2017        Price: US 2380 Onwards        Pages: 110
    The global Cellular Health Screening/Health Testing market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report offers an overview of the market trends, drivers, and barriers with respect to the Cellular Health Screening/Health Testing market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia ......
  • Global and United States Cellular Health Screening/Health Testing In-Depth Research Report 2017-2022
    Published: 16-Oct-2017        Price: US 3190 Onwards        Pages: 113
    The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Cellular Health Screening/Health Testing industry. Major Companies - Genova Diagnostics (U.S.) ......
  • Global Cellular Health Screening/Health Testing Detailed Analysis Report 2017-2022
    Published: 16-Oct-2017        Price: US 3250 Onwards        Pages: 114
    This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Cellular Health Screening/Health Testing industry. This report splits Cellular Health Screening/Health Testing market By Product Type, By Sample Type, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022. ......
  • Global and Europe Cellular Health Screening/Health Testing Market - Analysis and Outlook to 2022
    Published: 16-Oct-2017        Price: US 2960 Onwards        Pages: 121
    This report presents a comprehensive overview of the Cellular Health Screening/Health Testing market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Cellular Health Screening/Health Testing i......
  • 2017-2022 Global and Japan Cellular Health Screening/Health Testing Market Analysis Report
    Published: 16-Oct-2017        Price: US 3085 Onwards        Pages: 112
    The global Cellular Health Screening/Health Testing market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%. This report, with focus on top players in the global and Japan, studies the Cellular Health Screening/Health Testing mar......
  • Global and Regional In-Vitro Diagnostics (IVD) Market Research Report 2017
    Published: 11-Oct-2017        Price: US 3500 Onwards        Pages: 111
    Summary In-Vitro Diagnostics (IVD) is test that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Test equipment - Test Reagents B......
  • United States Thyroid Functioning Tests Market Report 2017
    Published: 04-Oct-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Thyroid Functioning Tests market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growt......
  • In Vitro Fertilization Market by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022
    Published: 04-Oct-2017        Price: US 5650 Onwards        Pages: 181
    “In Vitro Fertilization market is projected to grow at a CAGR of 10.9%” The global in vitro fertilization market is expected to grow at a CAGR of 10.9% to reach to USD 847.8 million by 2022. Factors propelling market growth include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment opt......
  • Global In Vitro Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts
    Published: 01-Oct-2017        Price: US 2995 Onwards        Pages: 660
    "Delivery of this report will take 1-3 days after purchase." The Global In Vitro Diagnostics Partnering 2010-2017 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest In Vitro Diagnostics agreements announced in the life sciences si......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs